1vkt

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
Functional surfaces of a protein are often mapped by combination of X-ray, crystallography and mutagenesis. Such studies of insulin have yielded, paradoxical results, suggesting that the native state is inactive and, reorganizes on receptor binding. Of particular interest is the N-terminal, alpha-helix of the A-chain. Does this segment function as an alpha-helix, or reorganize as recently proposed in a prohormone-convertase complex? To, correlate structure and function, we describe a mapping strategy based on, protein design. The solution structure of an engineered monomer ([AspB10, LysB28, ProB29]-human insulin) is determined at neutral pH as a template, for synthesis of a novel A-chain analogue. Designed by analogy to a, protein-folding intermediate, the analogue lacks the A6-A11 disulphide, bridge; the cysteine residues are replaced by serine. Its solution, structure is remarkable for segmental unfolding of the N-terminal A-chain, alpha-helix (A1 to A8) in an otherwise native subdomain. The structure, demonstrates that the overall orientation of the A and B chains is, consistent with reorganization of the A-chain's N-terminal segment., Nevertheless, the analogue's low biological activity suggests that this, segment, a site of clinical mutation causing diabetes mellitus, functions, as a preformed recognition alpha-helix.
+
Functional surfaces of a protein are often mapped by combination of X-ray crystallography and mutagenesis. Such studies of insulin have yielded paradoxical results, suggesting that the native state is inactive and reorganizes on receptor binding. Of particular interest is the N-terminal alpha-helix of the A-chain. Does this segment function as an alpha-helix or reorganize as recently proposed in a prohormone-convertase complex? To correlate structure and function, we describe a mapping strategy based on protein design. The solution structure of an engineered monomer ([AspB10, LysB28, ProB29]-human insulin) is determined at neutral pH as a template for synthesis of a novel A-chain analogue. Designed by analogy to a protein-folding intermediate, the analogue lacks the A6-A11 disulphide bridge; the cysteine residues are replaced by serine. Its solution structure is remarkable for segmental unfolding of the N-terminal A-chain alpha-helix (A1 to A8) in an otherwise native subdomain. The structure demonstrates that the overall orientation of the A and B chains is consistent with reorganization of the A-chain's N-terminal segment. Nevertheless, the analogue's low biological activity suggests that this segment, a site of clinical mutation causing diabetes mellitus, functions as a preformed recognition alpha-helix.
==Disease==
==Disease==
Line 16: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Burke, G.T.]]
+
[[Category: Burke, G T.]]
-
[[Category: Chu, Y.C.]]
+
[[Category: Chu, Y C.]]
-
[[Category: Frank, B.H.]]
+
[[Category: Frank, B H.]]
-
[[Category: Hu, S.Q.]]
+
[[Category: Hu, S Q.]]
-
[[Category: Hua, Q.X.]]
+
[[Category: Hua, Q X.]]
-
[[Category: Jia, W.H.]]
+
[[Category: Jia, W H.]]
-
[[Category: Katsoyannis, P.G.]]
+
[[Category: Katsoyannis, P G.]]
-
[[Category: Wang, S.H.]]
+
[[Category: Wang, S H.]]
-
[[Category: Weiss, M.A.]]
+
[[Category: Weiss, M A.]]
[[Category: disulfide model]]
[[Category: disulfide model]]
[[Category: hormone]]
[[Category: hormone]]
[[Category: human insulin]]
[[Category: human insulin]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:05:08 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:36:22 2008''

Revision as of 13:36, 21 February 2008


1vkt

Drag the structure with the mouse to rotate

HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES

Contents

Overview

Functional surfaces of a protein are often mapped by combination of X-ray crystallography and mutagenesis. Such studies of insulin have yielded paradoxical results, suggesting that the native state is inactive and reorganizes on receptor binding. Of particular interest is the N-terminal alpha-helix of the A-chain. Does this segment function as an alpha-helix or reorganize as recently proposed in a prohormone-convertase complex? To correlate structure and function, we describe a mapping strategy based on protein design. The solution structure of an engineered monomer ([AspB10, LysB28, ProB29]-human insulin) is determined at neutral pH as a template for synthesis of a novel A-chain analogue. Designed by analogy to a protein-folding intermediate, the analogue lacks the A6-A11 disulphide bridge; the cysteine residues are replaced by serine. Its solution structure is remarkable for segmental unfolding of the N-terminal A-chain alpha-helix (A1 to A8) in an otherwise native subdomain. The structure demonstrates that the overall orientation of the A and B chains is consistent with reorganization of the A-chain's N-terminal segment. Nevertheless, the analogue's low biological activity suggests that this segment, a site of clinical mutation causing diabetes mellitus, functions as a preformed recognition alpha-helix.

Disease

Known diseases associated with this structure: Diabetes mellitus, rare form OMIM:[176730], Hyperproinsulinemia, familial OMIM:[176730], MODY, one form OMIM:[176730]

About this Structure

1VKT is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue., Hua QX, Hu SQ, Frank BH, Jia W, Chu YC, Wang SH, Burke GT, Katsoyannis PG, Weiss MA, J Mol Biol. 1996 Nov 29;264(2):390-403. PMID:8951384

Page seeded by OCA on Thu Feb 21 15:36:22 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools